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Summary
The objective of this study was to monitor changes in ovarian status in heifers exposed to a 
progesterone insert with or without concurrent gonadotropin-releasing hormone (GnRH) injec-
tion. Estrus was manipulated in 283 heifers (31 breeding clusters) by administering GnRH, 
progesterone, and prostaglandin F2α (PGF2α) at 5 stages of the estrous cycle. Estrus was pre-
synchronized with a progesterone insert for 7 days before PGF2α was administered 24 hours 
before insert removal. Successive clusters of heifers were assigned to treatments (2 heifers per 
treatment) on cycle day 2, 5, 10, 15, and 18. Treatments consisted of a progesterone insert (day 
0) for 7 days plus (1) PGF2α on day 6, 24 hours before insert removal (early PGF); (2) GnRH on 
day 0 + early PGF2α (GnRH + early PGF); (3) PGF2α at insert removal (late PGF); or (4) GnRH 
on day 0 + late PGF (GnRH + late PGF). Controls received GnRH on day 0 and PGF2α on day 7. 
Ovaries were scanned by transrectal ultrasonography on days 0, 2, 7, 9, and 11 to assess fol-
licle diameters and ovulation. Blood was collected on days 0, 2, 6, 7, 8, and 9 to quantify serum 
concentrations of progesterone. Insemination occurred after detected estrus or by timed artifi-
cial insemination (TAI) 64 hours after insert removal. Only 25% of 141 GnRH-treated heifers 
ovulated by day 2; twice as many ovulated when treatment was initiated on day 5 (46.4%) than on 
other cycle days (20.3%). Compared with controls, progesterone concentration was greater in all 
progesterone-treated heifers on days 2 and 6. Early- vs. late-PGF treatment resulted in less pro-
gesterone on days 7 and 8. Pregnancy rates were less after TAI (44%) than after detected estrus 
(56%) and less in controls than in all progesterone treatments. Heifers in which treatments were 
initiated on day 10 of the cycle had the most consistent (estrus vs. TAI) pregnancy rates (65.4%) 
compared with heifers in which treatments were initiated on other cycle days. Compared with 
controls, more progesterone-treated heifers ovulated by 96 hours after insert removal. Applica-
tion of the progesterone insert reduced variance of the interval to estrus after insert removal (or 
PGF2α injection in controls) by 1.6-fold compared with controls. These results do not support 
use of GnRH in a progesterone-based synchronization protocol.
Introduction
A timed artificial insemination (TAI) protocol for heifers that provides consistently acceptable 
pregnancy rates is lacking. Attempts to use the Ovsynch protocol as a TAI protocol for dairy 
heifers have proved disappointing because of poor fertility of heifers with premature expression 
of estrus between the first GnRH injection and PGF2α. When estrus occurs prematurely after 
PGF2α, a single TAI will not produce a high likelihood of conception. Most heifer developers in 
the beef and dairy industries desire acceptable protocols that employ TAI.
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Earlier research in heifers using a progesterone-releasing intravaginal device (PRID), norges-
tomet implants, and the progesterone-releasing controlled internal drug release (CIDR) insert 
confirms the benefit of using a progestin to prevent premature expression of estrus. Expression 
of estrus in heifers was reported in those studies after various treatment combinations of proges-
tins (PRID for 6 or 7 days, norgestomet for 7 days, or CIDR for 7 days, respectively) and PGF2α 
given at or 24 hours before progestin withdrawal. Estrus tended to be more closely synchronized 
in heifers treated with PGF2α 24 hours before progestin withdrawal than in those treated with 
PGF2α concurrent with progestin removal or with PGF2α alone. When PGF2α was injected 24 
hours before removal of the PRID or norgestomet, 76% of treated heifers were in estrus during a 
24-hour period.
A recent study in beef heifers employed GnRH, progesterone (CIDR), and PGF2α and combina-
tions of detected estrus before AI, TAI, or both. In that 12-location study, the treatment in which 
GnRH was administered concurrently with a 7-day progesterone insert and TAI conducted 60 
hours after insert removal and PGF2α injection consistently produced  the best pregnancy rates 
across locations. Necessity of the upfront GnRH injection is questionable because small differ-
ences (2.8 to 4 percentage points) in pregnancy rates were detected for heifers receiving and not 
receiving that injection.
The hypothesis of the current experiment was that including a progestin in a GnRH + PGF2α 
protocol could prevent premature expression of estrus to facilitate TAI without loss of fertility. 
Variation in fertility may depend on effectiveness of the upfront GnRH injection to ovulate a 
dominant follicle. Further, turnover of a dominant follicle in nulliparous heifers is less successful 
than in lactating dairy cows, and little is known about follicle turnover or ovulatory response to 
GnRH in heifers treated concurrently with progesterone.
The objective of the current study was to assess follicular responses, ovulation, luteal function 
(concentrations of progesterone in serum), and incidences of estrus in response to combinations 
of GnRH, PGF2α, and progesterone applied for synchronization of estrus, ovulation, or both in 
nulliparous replacement heifers. An ancillary objective was to monitor pregnancy rates to deter-
mine whether a TAI protocol was feasible after using protocols consisting of GnRH, PGF2α, and 
progesterone.
Experimental Procedures
Holstein heifers ranging in age from 11.6 to 16.5 months (13.3 ± 0.95 months; mean ± SD) 
and body weight from 315 to 501 kg (410 ± 34 kg; mean ± SD) were housed at the Kansas State 
University Dairy Teaching and Research Center (Manhattan, KS) and maintained on dry lots with 
covered freestalls and a concrete feed apron. Heifers were fed a total mixed ration consisting of 
chopped prairie or alfalfa hay, corn or milo grain, soybean meal, and minerals and vitamins to 
exceed National Research Council guidelines for growing heifers.
Estrous cycles of dairy heifers (electronic estrus-detection patches were applied; HeatWatch, 
Cow Chips, LLC, Denver, CO) were presynchronized by placing a progesterone insert contain-
ing 1.38 g progesterone (Eazi-Breed CIDR, Pfizer Animal Health, New York, NY) for 7 days and 
administering 25 mg PGF2α (Lutalyse, Pfizer Animal Health, New York, NY) 24 hours before 
insert removal. After detection of estrus, heifers were assigned randomly to treatment schemes at 
5 stages of the estrous cycle (days 2, 5, 10, 15, and 18).
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Between February 2003 and March 2006, estrous cycles of 31 clusters of heifers (10 heifers  
per cluster except for 8 clusters that varied in size from 5 to 12 heifers) were presynchronized  
as described previously to initiate treatments in a rotating pattern starting on cycle day 2, 5, 10, 
15, and 18, and then that pattern was repeated during the course of the experiment. Generally,  
2 heifers per cluster were assigned randomly to each of 5 treatment schemes (Figure 1) consist-
ing of a progesterone insert (day 0) for 7 days plus (1) 25 mg of PGF2α (Lutalyse) on day 6,  
24 hours before insert removal (early PGF); (2) 100 µg GnRH (Cystorelin, Merial, Athens, GA) 
on day 0 + PGF2α on day 6 (GnRH + early PGF); (3) PGF2α at insert removal (day 7; late PGF); 
or (4) 100 µg GnRH on day 0 + late PGF2α (GnRH + late PGF) and (5) controls, which only 
received GnRH on day 0 and PGF2α on day 7.
Blood was collected from a coccygeal blood vessel on days 0, 2, 6, 7, 8, and 9 (Figure 1). Blood 
sera concentrations of progesterone were later quantified by radioimmunoassay. Ovaries were 
examined by transrectal ultrasonography on days 0, 2, 7, 9, and 11 from initiation of each syn-
chronization treatment to assess diameter of all follicles > 5 mm (days 0, 2, 6, 7, and 9), evidence 
for ovulation on day 2 in heifers treated with GnRH on day 0, and evidence for post-AI ovulation 
(day 11 or 96 hours after insert removal).
Heifers were inseminated either on the basis of standing estrus (detected by HeatWatch) or 
at 63.7 ± 0.8 (SD) hours (range of 61 to 65 hours) after removal of the insert. Pregnancy was 
diagnosed by transrectal ultrasonography at 32 or 33 days after AI. Presence of a viable embryo 
(heartbeat) was evidence for a confirmed pregnancy. Pregnancy rates were calculated as number 
of heifers pregnant after AI divided by total number of heifers inseminated.
Results and Discussion
Heifers in 2 treatments received GnRH concurrent with insertion of the progesterone insert; the 
control (no progesterone) received GnRH at the same time. The proportion of heifers with new 
ovulatory structures was evaluated 48 hours after GnRH injection. Only 25.1% of 141 heifers 
had new luteal structures, and a new CL was detected 48 hours after progesterone treatment in 1 
heifer on cycle day 2 (Table 1). Proportions were similar among the 3 treatments in which GnRH 
was administered. More (P < 0.05) heifers ovulated on cycle day 5 than at any other stage of the 
cycle. No interaction was detected between stage of cycle and treatment. Concurrent administra-
tion of progesterone via the insert did not reduce subsequent ovulation because proportions of 
control heifers having a new luteal structure 48 hours after GnRH: day 2 (22.2%, 2/9); day 5  
(55.6%, 5/9); day 10 (11.1%, 1/9); day 15 (30%, 3/10; and day 18 (27.2%, 3/11) were simi-
lar to GnRH- and progesterone-treated heifers: day 2 (21.1%, 4/19); day 5 (42.1%, 8/19);  
day 10 (22.2%, 4/18); day 15 (21.1%, 4/19); and day 18 (11.1%, 2/18).
Regardless of treatment, stage of estrous cycle at onset of treatment influenced largest follicle 
diameter on experimental day 2 because late-cycle heifers (day 15 = 9.4 ± 0.6 mm and day  
18 = 8.6 ± 0.6 mm) had larger (P < 0.05) follicles than cycle day 10 heifers (6.1 ± 0.7 mm). By 
day 7, these differences were negligible, but by day 9, the largest follicle was greater (P < 0.05) 
in diameter for heifers initiating treatment on cycle days 2 (13.5 ± 0.4 mm), 10 (13.3 ± 0.4 
mm), and 18 (14.6 ± 0.5 mm) than on cycle day 5 (11.7 ± 0.4 mm).
Concentrations of progesterone assessed on experimental days 0, 2, 6, 7, 8, and 9 are illustrated 
in Figure 2. At the onset of treatment, concentration of progesterone did not differ among heif-
ers assigned to various treatments. By 48 hours after onset of treatment, progesterone-treated 
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heifers had greater (P < 0.001) concentrations than controls. This difference (P < 0.05) per-
sisted until day 6, but among progesterone-treated heifers, those that received GnRH tended  
(P = 0.08) to have greater concentrations of progesterone than those not treated with GnRH.  
On day 7, 24 h after early PGF heifers were injected with PGF2α, progesterone was reduced 
compared with late PGF heifers. By day 8, 24 hours after insert removal, early PGF heifers 
tended (P = 0.08) to maintain lower concentrations of progesterone than late PGF heifers. By 
day 9, all progesterone-treated heifers had less (P < 0.001) progesterone than controls.
Distribution of estrus after insert removal on experimental day 7 is illustrated in Figure 3. In-
cluded in this comparison are combined treatment responses and presynchronizaton response of 
all heifers (pre-early PGF) in which heifers received a progesterone insert for 7 days and PGF2α 
was injected 24 hours before insert removal (as in the early PGF treatment). Injection of GnRH 
on day 0 had no effect on onset of estrus; thus, the 2 early PGF treatments were combined as 
were the 2 late PGF treatments.
Among progesterone-treated heifers, distribution of estrus was shifted slightly to the left for 
those treated with PGF2α 24 hours before insert removal compared with those receiving PGF2α at 
insert removal. Both the pre-early PGF and early PGF (treated similar to pre-early PGF) had simi-
lar distribution patterns. Mean intervals to estrus were 44.8 ± 2.1 (pre-early PGF), 45.3 ± 3.2 
(early PGF), 52.6 ± 3.3 (late PGF), and 33.4 ± 4.8 hours (control). Variances were 1,013, 829, 
768, and 2,718, respectively. Variance of the first 3 groups was less (P < 0.001) than that of the 
control (Levene’s test). Distribution pattern of controls was more variable because no progester-
one insert was used to prevent premature expression of estrus in heifers started on treatment on 
cycle days 15 and 18.
Although heifers receiving PGF2α 24 hours before insert removal were in estrus 2 to 10 hours 
earlier than comparable late PGF heifers, interval to estrus did not differ. Controls had a shorter 
(P < 0.05) interval to estrus than all heifers receiving progesterone inserts. Variances also dif-
fered (P < 0.001) among treatments and were 1.3 to 1.6 greater in control than progesterone 
treatments.
Post-treatment ovulation by 96 hours after insert removal is reported in Table 1. Incidence of 
ovulation was less (P < 0.05) in controls compared with progesterone treatments. Day of cycle at 
which treatment was initiated affected (P = 0.001) ovulation. Least incidence of post-treatment 
ovulation occurred in heifers initiating treatment on cycle day 2, and the best incidence of ovula-
tion was detected in cycle day 10 heifers. Reduced post-treatment ovulation in control heifers 
was a result of premature expression of estrus and early ovulation before treatment with PGF2α 
and more luteolytic failures.
Pregnancy rates were recorded, but inadequate numbers of heifers were treated to detect poten-
tial differences in fertility (Table 2). Nonetheless, pregnancy rates in control heifers differed  
(P < 0.05) from those in heifers that received progesterone, and pregnancy rates after TAI were 
less (P < 0.05) than those in heifers inseminated after detected estrus. Numerically greater preg-
nancy rates were observed in late PGF (51.5%) than early PGF (41.3%) treatments regardless of 
GnRH administration. Cycle day 10 heifers had the most consistent pregnancy rates exceeding 
65% regardless whether insemination occurred after detected estrus or by appointment.
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One objective was to determine ovarian follicular responses to GnRH and subsequent ovulation 
after treatment. Injection of GnRH was rather ineffective in inducing ovulation in dairy heifers 
(Table 1) compared with earlier reports in heifers. Although others have suggested heifers tend 
to have a lesser ovulatory response to GnRH than cows because of shorter follicular waves and 
dominant follicles of lesser maximum diameter, a major difference in our study was the concur-
rent inclusion of a progesterone insert at the time of GnRH injection in all but controls.
Ovulatory response to GnRH was poor and similar regardless whether GnRH administration was 
concurrent with progesterone. Injection of GnRH resulted in smaller follicle diameters 2 days af-
ter treatment, but compensation in rate of follicle growth produced follicles of similar size 7 days 
later. Injection of GnRH tended to increase serum progesterone at day 6 after onset of treatment 
but had no effect of interval to or duration of estrus. In contrast, GnRH-treated heifers received 
more mounts of greater duration during estrus. Pregnancy rates were reduced in heifers receiv-
ing TAI 64 hours after insert removal compared with those inseminated after detection of estrus. 
Pregnancy rates were less in controls not treated with progesterone. Administration of proges-
terone resulted in a more consistent and less variable pattern of estrus distribution compared 
with controls. Heifers initiating treatment on day 10 seemed to have the best pregnancy rates 
regardless whether inseminated after estrus or by appointment 64 hours after insert removal. 
No difference in average or variance of interval to estrus after insert removal regardless whether 
PGF2α was injected at or 24 hours before insert removal justifies concurrent insert removal and 
PGF2α injection. Although nonsignificant, pregnancy rates favored that management choice.
Table 1. Incidence of ovulation after gonadotropin-releasing hormone (GnRH) and post-treat-
ment on the basis of stage of cycle at onset of treatment
% ovulation1 (no.)
Item Response to GnRH2 Post-treatment2
Treatment2
     Early PGF2α  2.1
a (47) 91.5a (47)
     GnRH + early PGF2α 28.9
b (45) 88.9a (45
     Late PGF2α  0.0
a (47) 89.4a (47)
     GnRH + late PGF2α 18.8
b (48) 89.6a (48)
     Control 29.2b (48) 68.8b (48)
Day of estrous cycle3
     2 21.4a (28) 75.6ab (45)
     5 46.4b (28) 78.0a (50)
     10 18.5a (27) 100.0c (45)
     15 24.1a (29) 87.8bc (49)
     18 17.2a (29) 87.0bc (46)
a-c Mean percentages within column and item having different superscript letters differ (P < 0.05).
1 Determined by transrectal ultrasonographic evidence of follicle disappearance and presence of new luteal tissue 48 hours 
after GnRH injection or 96 hours after progesterone insert removal.
2 All treatments except control included a 7-day progesterone insert with or without a concurrent injection of GnRH, and 
prostaglandin F2α (PGF2α) was given either at insert removal or 24 hours earlier. Control heifers received GnRH followed in 7 
days by PGF2α.
3 Stage of estrous cycle at onset of treatment. Excludes heifers in GnRH + early PGF2α and GnRH + later PGF2α heifers that did 
not receive a GnRH injection.
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Table 2. Pregnancy rates in response to treatment with gonadotropin-releasing hormone 
(GnRH), progesterone, and prostaglandin F2α (PGF2α) after detected estrus or timed artificial 
insemination (TAI)1
% Pregnant (no.)
Item Estrus TAI Total
Treatment2
     Early PGF2α 53.3 (15) 40.0 (40) 43.6
x (55)
     GnRH + Early PGF2α 50.0 (16) 42.5 (40) 44.6
x (56)
     Late PGF2α 42.9 ( 7) 54.2 (48) 52.7
x (55)
     GnRH + Late PGF2α 63.6 (11) 49.0 (49) 51.7
x (60)
     Control 75.0 ( 8) 30.4 (46) 37.0y (54)
Total 56.1a (57) 44.0b (223) 46.4 (280)
Early PGF2α 51.6 (31) 41.3 (80) 44.1 (111)
Late PGF2α 55.6 (18) 51.5 (97) 52.2 (115)
Day of estrous cycle3
     2 66.7 ( 6) 34.7 (49) 38.2 (55)
     5 33.3 ( 3) 37.9 (58) 37.7 (61)
     10 66.7 ( 9) 65.2 (46) 65.4 (55)
     15 62.5 (16) 42.5 (40) 48.2 (56)
     18 47.8 (23) 36.7 (30) 41.5 (53)
a-b Mean percentages within row having different superscript letters differ (P < 0.05). 
x-y Mean percentages within column having different superscript letters differ (P < 0.05). 
1 Pregnancy rates determined by transrectal ultrasonographic evidence of fluid, embryonic heart beat, and presence of a corpus 
luteum at 32 to 33 days post-TAI. 
2 All treatments except control included a 7-day insert with or without a concurrent injection of GnRH, and PGF2α was given at 
either insert removal or 24 hours earlier. Control heifers received GnRH followed in 7 days by PGF2α. 
3 Stage of estrous cycle at onset of treatment.
18
DAIRY RESEARCH 2008
                CIDR
                CIDR
Days from GnRH
US       US                          US US              US
 B          B                    B     B        B        B
    CIDR
                CIDR
PGF
PGF
PGF
PGF
PGF
GnRH
GnRH
GnRH
Early PGF
GnRH +
Early PGF
Late PGF
GnRH +
Late PGF
Control
Figure 1. Experimental design of treatments. All treatments except control included a 7-day 
progesterone insert with or without a concurrent injection of GnRH. An injection of PGF2α 
(PGF) was given either at insert removal or 24 hours earlier. Control heifers received GnRH 
followed in 7 days by PGF2α. CIDR = 1.38 g of progesterone controlled internal drug release 
insert; GnRH = 100 µg of GnRH; PGF = 25 mg of PGF2α; US = transrectal ultrasonography; and 
B = blood collection. 
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Figure 2. Treatment effects on concentrations of progesterone beginning at the onset of  
treatment (day 0) until 2 days after progesterone insert removal. All treatments except control 
included a 7-day insert with or without a concurrent injection of GnRH. An injection of PGF2α 
(PGF) was given either at insert removal or 24 hours earlier. Control heifers received GnRH  
followed in 7 days by PGF2α. Five treatments were (1) early PGF (n = 56), (2) GnRH + early 
PGF (n = 56), (3) late PGF (n = 55), (4) GnRH + late PGF (n = 60), and (5) control (n = 55). 
Contrasts are progesterone insert (CIDR) vs. control, GnRH vs. no GnRH (progesterone insert 
treatments only), and early vs. late PGF. 
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Figure 3. Pattern of post-treatment estrus. Distribution of estrus after either early administra-
tion of PGF2α (PGF; 24 hours before a 7-day progesterone insert was removed from all heifers 
during pretreatment synchronization of estrus; n = 247), early PGF2α (24 hours before insert 
removal) during treatment (n = 105), late PGF2α concurrent with insert removal (n = 99), or in 
controls (GnRH 7 days before PGF2α; n = 47).
